Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

aehr test systems - AEHR

AEHR

Close Chg Chg %
23.00 3.39 14.74%

Closed Market

26.39

+3.39 (14.74%)

Volume: 843.24K

Last Updated:

Feb 6, 2026, 4:00 PM EDT

Trade Now

Company Overview: aehr test systems - AEHR

AEHR Key Data

Open

$24.00

 Day Range

23.80 - 26.63

52 Week Range

6.27 - 34.35

 Market Cap

$729.85M

Shares Outstanding

30.63M

 Public Float

28.45M

Beta

2.32

 Rev. Per Employee

N/A

P/E Ratio

N/A

 EPS

-$0.30

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.31M

  

AEHR Performance

1 Week
 
 2.93%
 
1 Month
 
 0.27%
 
3 Months
 
 7.80%
 
1 Year
 
 144.81%
 
5 Years
 
 934.90%
 

AEHR Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 4
Full Ratings ➔

About aehr test systems - AEHR

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

AEHR At a Glance

Aehr Test Systems
400 Kato Terrace
Fremont, California 94539
Phone 1-510-623-9400 Revenue 58.97M
Industry Electronic Production Equipment Net Income -3,910,000.00
Sector Electronic Technology Employees 136
Fiscal Year-end 05 / 2026
View SEC Filings

AEHR Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 4.786
Price to Book Ratio 2.32
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -289.518
Enterprise Value to Sales 4.542
Total Debt to Enterprise Value 0.04

AEHR Efficiency

Revenue/Employee 433,588.235
Income Per Employee -28,750.00
Receivables Turnover 3.314
Total Asset Turnover 0.427

AEHR Liquidity

Current Ratio 5.677
Quick Ratio 2.991
Cash Ratio 1.613

AEHR Profitability

Gross Margin 40.586
Operating Margin -7.314
Pretax Margin -7.277
Net Margin -6.631
Return on Assets -2.829
Return on Equity -3.335
Return on Total Capital -2.924
Return on Invested Capital -3.127

AEHR Capital Structure

Total Debt to Total Equity 8.814
Total Debt to Total Capital 8.10
Total Debt to Total Assets 7.293
Long-Term Debt to Equity 8.074
Long-Term Debt to Total Capital 7.42
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Aehr Test Systems - AEHR

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
50.83M 64.96M 66.22M 58.97M
Sales Growth
+206.20% +27.80% +1.94% -10.95%
Cost of Goods Sold (COGS) incl D&A
27.16M 32.22M 33.67M 35.03M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
307.00K 450.00K 1.36M 3.39M
Depreciation
307.00K 450.00K 1.36M 2.19M
Amortization of Intangibles
- - - 1.20M
-
COGS Growth
+157.04% +18.59% +4.53% +4.04%
Gross Income
23.66M 32.75M 32.54M 23.93M
Gross Income Growth
+292.32% +38.37% -0.62% -26.46%
Gross Profit Margin
+46.56% +50.41% +49.15% +40.59%
2022 2023 2024 2025 5-year trend
SG&A Expense
15.87M 19.37M 22.46M 28.25M
Research & Development
5.82M 7.13M 8.72M 10.46M
Other SG&A
10.05M 12.24M 13.75M 17.78M
SGA Growth
+55.33% +22.10% +15.97% +25.73%
Other Operating Expense
- - - -
-
Unusual Expense
- - (1.70M) 1.36M
-
EBIT after Unusual Expense
9.50M 13.38M 10.08M (5.68M)
Non Operating Income/Expense
43.00K 1.24M 2.38M 1.39M
Non-Operating Interest Income
13.00K 1.25M 2.39M 1.40M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - -
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - -
-
Interest Capitalized
- - - -
-
Pretax Income
9.54M 14.62M 12.46M (4.29M)
Pretax Income Growth
+532.89% +53.20% -14.77% -134.44%
Pretax Margin
+18.77% +22.50% +18.81% -7.28%
Income Tax
91.00K 60.00K (20.70M) (381.00K)
Income Tax - Current - Domestic
91.00K 28.00K 20.00K 7.00K
Income Tax - Current - Foreign
- 32.00K 55.00K 33.00K
Income Tax - Deferred - Domestic
- - (20.77M) (421.00K)
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
9.45M 14.56M 33.16M (3.91M)
Minority Interest Expense
- - - -
-
Net Income
9.45M 14.56M 33.16M (3.91M)
Net Income Growth
+566.21% +54.04% +127.77% -111.79%
Net Margin Growth
+18.59% +22.41% +50.07% -6.63%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
9.45M 14.56M 33.16M (3.91M)
Preferred Dividends
- - - -
-
Net Income Available to Common
9.45M 14.56M 33.16M (3.91M)
EPS (Basic)
0.3633 0.5239 1.1505 -0.1322
EPS (Basic) Growth
+520.49% +44.21% +119.60% -111.49%
Basic Shares Outstanding
26.01M 27.79M 28.82M 29.58M
EPS (Diluted)
0.3402 0.4983 1.1195 -0.1322
EPS (Diluted) Growth
+493.75% +46.47% +124.66% -111.81%
Diluted Shares Outstanding
27.77M 29.21M 29.62M 29.58M
EBITDA
8.11M 13.82M 11.44M (925.00K)
EBITDA Growth
+309.38% +70.53% -17.24% -108.08%
EBITDA Margin
+15.95% +21.28% +17.28% -1.57%

Snapshot

Average Recommendation HOLD Average Target Price 24.667
Number of Ratings 4 Current Quarters Estimate -0.07
FY Report Date 02 / 2026 Current Year's Estimate -0.125
Last Quarter’s Earnings -0.04 Median PE on CY Estimate N/A
Year Ago Earnings 0.15 Next Fiscal Year Estimate 0.076
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 4 4 4 4
Mean Estimate -0.07 -0.02 -0.12 0.08
High Estimates -0.05 0.00 -0.09 0.20
Low Estimate -0.09 -0.04 -0.16 0.03
Coefficient of Variance -25.85 -119.67 -22.79 110.13

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 0
OVERWEIGHT 0 0 0
HOLD 3 3 3
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Hold Hold Hold

Insider Actions for Aehr Test Systems - AEHR

Date Name Shares Transaction Value
Jan 27, 2026 Laura Oliphant Director; Director 19,878 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $31.38 per share 623,771.64
Jan 27, 2026 Laura Oliphant Director; Director 18,852 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $31.44 per share 592,706.88
Jan 27, 2026 Laura Oliphant Director; Director 18,672 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $31.45 per share 587,234.40
Jan 27, 2026 Laura Oliphant Director; Director 18,572 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $31.46 per share 584,275.12
Jan 27, 2026 Laura Oliphant Director; Director 18,432 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $31.48 per share 580,239.36
Oct 10, 2025 Gayn Erickson President and CEO; Director 269,153 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $32.25 per share 8,680,184.25
Jul 10, 2025 Fariba Nobakht Danesh Director; Director 25,643 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 8, 2025 Donald P. Richmond CTO 214,719 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 8, 2025 Donald P. Richmond CTO 216,361 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 8, 2025 Donald P. Richmond CTO 216,140 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $15.13 per share 3,270,198.20
Apr 15, 2025 Gayn Erickson President and CEO; Director 193,540 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $8.3 per share 1,606,382.00
Apr 15, 2025 Vernon Rogers Exec VP of Sales & Mktg. 50,092 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $8.52 per share 426,783.84
Apr 15, 2025 Vernon Rogers Exec VP of Sales & Mktg. 49,366 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $8.3 per share 409,737.80
Apr 3, 2025 Adil Engineer Chief Operating Officer 28,092 Other acquisition or disposition Non-derivative transaction at $6.67 per share 187,373.64
Feb 26, 2025 Alberto Salamone EVP, PPBI BUSINESS 58,571 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $10.77 per share 630,809.67

Aehr Test Systems in the News